Compile Data Set for Download or QSAR
maximum 50k data
Found 24 for UniProtKB: Q04400
LigandPNGBDBM78433(2-[4-[3-[2-(trifluoromethyl)-10-phenothiazinyl]pro...)
Affinity DataIC50:  80nMAssay Description:The compound was tested for adenylate cyclase activity in rat corpus striatumMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50001888((chloropromazine) [3-(2-Chloro-phenothiazin-10-yl)...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibitory concentration against Dopamine sensitive adenylate cyclase in ratsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50140057(2-Hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetra...)
Affinity DataIC50:  2.80E+3nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50370376(CHEMBL1229920)
Affinity DataIC50:  4.60E+3nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50025883((2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymet...)
Affinity DataIC50:  1.50E+4nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50008363(5-(6-Amino-2-fluoro-purin-9-yl)-2-hydroxymethyl-te...)
Affinity DataIC50: >1.00E+5nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM14487((2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxy...)
Affinity DataIC50: >3.00E+5nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032516((6aR,12bS)-4-Methyl-6-propyl-5,6,6a,7,8,12b-hexahy...)
Affinity DataEC50:  333nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032521((6aR,12bS)-5,6,6a,7,8,12b-Hexahydro-benzo[a]phenan...)
Affinity DataEC50:  148nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032522((6aR,12bS)-2-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  114nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032524((6aR,12bS)-5,6,6a,7,8,12b-Hexahydro-benzo[a]phenan...)
Affinity DataEC50:  130nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032518((6aR,12bS)-3-Methyl-6-propyl-5,6,6a,7,8,12b-hexahy...)
Affinity DataEC50:  10nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50009864(CHEMBL274833 | [2-Methyl-1-(2-morpholin-4-yl-ethyl...)
Affinity DataEC50:  370nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50009854(CHEMBL13078 | [1-(2-Morpholin-4-yl-ethyl)-1H-indol...)
Affinity DataEC50:  275nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50050489(CHEMBL61448 | [6-Isothiocyanato-1-(2-morpholin-4-y...)
Affinity DataEC50:  1.10E+3nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50050491((4-Isothiocyanato-naphthalen-1-yl)-[2-methyl-1-(2-...)
Affinity DataEC50:  3.00E+3nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032519((6aR,12bS)-2-Phenyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  10nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032517((6aR,12bS)-2-Ethyl-5,6,6a,7,8,12b-hexahydro-benzo[...)
Affinity DataEC50:  610nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50010684((6aR,12bS)-6-Propyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50: >10nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50010686((6aR,12bS)-10,11-Dihydroxy-5,6,6a,7,8,12b-hexahydr...)
Affinity DataEC50:  141nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032520((6aR,12bS)-3-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  134nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50032523((6aR,12bS)-4-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  151nMAssay Description:Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50010686((6aR,12bS)-10,11-Dihydroxy-5,6,6a,7,8,12b-hexahydr...)
Affinity DataEC50:  51nMAssay Description:Tested for effective dose agonist activity against adenylate cyclase in rat striatal membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Rattus norvegicus)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50010686((6aR,12bS)-10,11-Dihydroxy-5,6,6a,7,8,12b-hexahydr...)
Affinity DataEC50:  60nMAssay Description:Effective concentration of the compound against adenylate cyclaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed